---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300712222.md"
description: "During Thursday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Nexalin Technology (up 77.8%), Stablecoin Development (up 41.31%), and Quantum-Si (up 28.97%). Conversely, notable losers were NewGenIvf Group (down 38.9%), PAVmed (down 25.48%), and Foghorn Therapeutics (down 24.37%). The report highlights specific price movements and market capitalizations for these companies."
datetime: "2026-10-01T17:06:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300712222.md)
  - [en](https://longbridge.com/en/news/300712222.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300712222.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Nexalin Technology** (NASDAQ:NXL) shares increased by 77.8% to $7.61 during Thursday's regular session. The company's market cap stands at $3.5 million.
-   **Stablecoin Development** (AMEX:SDEV) stock rose 41.31% to $3.66. The market value of their outstanding shares is at $70.2 million.
-   **Quantum-Si** (NASDAQ:QSI) shares moved upwards by 28.97% to $1.38. The company's market cap stands at $234.2 million.
-   **LeonaBio** (NASDAQ:LONA) shares rose 19.04% to $4.25. The company's market cap stands at $33.6 million.
-   **DataMEDS AI** (NASDAQ:MEDS) stock increased by 18.61% to $3.76. The market value of their outstanding shares is at $10.1 million.
-   **Inogen** (NASDAQ:INGN) shares moved upwards by 16.22% to $6.12. The company's market cap stands at $139.8 million.

### Losers

-   **NewGenIvf Group** (NASDAQ:NIVF) shares declined by 38.9% to $0.1 during Thursday's regular session.
-   **PAVmed** (NASDAQ:PAVM) stock decreased by 25.48% to $2.75. The company's market cap stands at $36.3 million.
-   **Foghorn Therapeutics** (NASDAQ:FHTX) stock declined by 24.37% to $2.7. The company's market cap stands at $212.0 million.
-   **Nektar Therapeutics** (NASDAQ:NKTR) stock decreased by 21.3% to $47.65. The company's market cap stands at $2.0 billion.
-   **Lucid Diagnostics** (NASDAQ:LUCD) shares declined by 20.04% to $0.6. The company's market cap stands at $143.4 million.
-   **AgomAb Therapeutics** (NASDAQ:AGMB) stock decreased by 14.96% to $9.44. The market value of their outstanding shares is at $546.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [AGMB.US](https://longbridge.com/en/quote/AGMB.US.md)
- [ATHA.US](https://longbridge.com/en/quote/ATHA.US.md)
- [FHTX.US](https://longbridge.com/en/quote/FHTX.US.md)
- [INGN.US](https://longbridge.com/en/quote/INGN.US.md)
- [LONA.US](https://longbridge.com/en/quote/LONA.US.md)
- [LUCD.US](https://longbridge.com/en/quote/LUCD.US.md)
- [MEDS.US](https://longbridge.com/en/quote/MEDS.US.md)
- [NBY.US](https://longbridge.com/en/quote/NBY.US.md)
- [NIVF.US](https://longbridge.com/en/quote/NIVF.US.md)
- [NKTR.US](https://longbridge.com/en/quote/NKTR.US.md)
- [NXL.US](https://longbridge.com/en/quote/NXL.US.md)
- [PAVM.US](https://longbridge.com/en/quote/PAVM.US.md)
- [QSI.US](https://longbridge.com/en/quote/QSI.US.md)
- [SDEV.US](https://longbridge.com/en/quote/SDEV.US.md)

## Related News & Research

- [Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment](https://longbridge.com/en/news/300677822.md)
- [Nektar Reports Durable Rezpegaldesleukin Data In Alopecia Areata And Atopic Dermatitis](https://longbridge.com/en/news/300697939.md)
- [Guggenheim maintains Buy rating on Foghorn Therapeutics, $5 price target](https://longbridge.com/en/news/300796134.md)
- [Foghorn Therapeutics cuts workforce about 40% in reorganization to extend cash runway into H2 2029](https://longbridge.com/en/news/300674623.md)
- [Foghorn Therapeutics Provides Update On Fhd-909 And Strategic Priorities](https://longbridge.com/en/news/300674432.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**